New Treatment for ED After Prostate Surgery Being Developed, Researchers Say

UPI - April 19, 2021

David Sharp, Ph.D., discusses a study, co-led with Kelvin Davies, M.Sc., Ph.D., detailing the development of a topical drug that, in rats, regenerates and restores the function of erectile nerves damaged by radical prostatectomy, the most common treatment for localized prostate cancer. Dr. Sharp is professor of physiology & biophysics and of ophthalmology and visual sciences and professor in the Dominick P. Purpura Department of Neuroscience at Einstein. Dr. Davies is professor of urology and of physiology & biophysics at Einstein.

Biotech Companies Seek to Restore Functions to Spinal-Cord Injury Patients

The Wall Street Journal - March 11, 2021

David Sharp, Ph.D., discusses a drug, discovered in his lab and licensed to a company he co-founded, that in preclinical studies helped regenerate nerve cells damaged in spinal-cord injuries. Dr. Sharp is professor of physiology & biophysics, of ophthalmology and visual sciences, and in the Dominick P. Purpura Department of Neuroscience.